The recently announced 2024 to 2025 UK national action plan (NAP)1 to address antimicrobial resistance (AMR) is the second 5-year phase of a 20-year strategy announced in 2019, building on initiatives in the first phase that include reducing antibiotics in food-producing animals, improving antimicrobial utilization surveillance systems, and piloting new payment schemes to support development of effective antibiotics. "AMR is a pervasive threat," the UK plan declares."The emergence of infections is relentless, while the pipeline for new antibiotics has run dry.Through this national action plan, we set out the challenge to the UK and to other counties to continue our excellent work to confront AMR, to preserve and develop these essential medicines for generations to come, and help us address one of the most pressing challenges we face this century."
The UK NAP arose several years after the US action plan2 commenced in 2013, but shares major objectives as well as the organization into 5-year phases to facilitate updating priorities, and taking stock of progress and obstacles.The objectives described inthe US plan are: responding to new and going antimicrobial threats; strengthening detection of AMR; slowing emergence and spread of AMR; improving antibiotic and antifungal use; advancing development of rapid diagnostics for antimicrobial-resistant pathogens; enhancing infection control measures to prevent resistant infections; and accelerating research on new antibiotics, antifungals, and other therapeutics and vaccines.
The 2024-2029 UK NAP organizes 9 strategic outcomes under 4 themes. Within the theme of reducing the need for, and unintentional exposure to antimicrobials, strategic outcomes are to: implement a range of infection prevention and control management programs for humans, animals, agriculture and the environment; educate and engage the public; and strengthen surveillance.
In the theme of optimizing use of antimicrobials, the two outcomes are: improved antimicrobial stewardship and disposal; and building a well functioning AMR workforce in human and animal health and in agriculture.